Implication of VDR rs7975232 and FCGR2A rs1801274 gene polymorphisms in the risk and the prognosis of
autoimmune thyroid diseases in the Tunisian population
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Invemizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun. 2009; 33(1): 12-16.InvemizziPPasiniSSelmiCGershwinMEPoddaMFemale predominance and X chromosome defects in autoimmune diseasesJ Autoimmun2009331121610.1016/j.jaut.2009.03.00519356902Search in Google Scholar
Weetman AP. Determinants of autoimmune thyroid disease. Nat Immunol. 2001; 2(9): 769-770.WeetmanAPDeterminants of autoimmune thyroid diseaseNat Immunol20012976977010.1038/ni0901-76911526381Search in Google Scholar
Ramos-Levi AM, Marazuela M. Pathogenesis of thyroid autoimmune disease: The role of cellular mechanisms. Endocrinol Nutr. 2016; 63(8): 421-429.Ramos-LeviAMMarazuelaMPathogenesis of thyroid autoimmune disease: The role of cellular mechanismsEndocrinol Nutr201663842142910.1016/j.endonu.2016.04.00327234136Search in Google Scholar
Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, et al. Regulation of apoptosis in endocrine autoimmunity: Insights from Hashimoto’s thy-roiditis and Graves’ disease. Ann NY Acad Sci. 2002; 966(1): 496-501.SalmasoCBagnascoMPesceGMontagnaPBrizzolaraRAltrinettiVet alRegulation of apoptosis in endocrine autoimmunity: Insights from Hashimoto’s thy-roiditis and Graves’ diseaseAnn NY Acad Sci2002966149650110.1111/j.1749-6632.2002.tb04253.x12114310Search in Google Scholar
Giovinazzo S, Vicchio TM, Certo R, Alibrandi A, Palmieri O, Campennì A, et al. Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH) D3 levels in Hashimoto’s thyroiditis. Endocrine. 2017; 55(2): 599-606.GiovinazzoSVicchioTMCertoRAlibrandiAPalmieriOCampennìAet alVitamin D receptor gene polymorphisms/haplotypes and serum 25(OH) D3 levels in Hashimoto’s thyroiditisEndocrine201755259960610.1007/s12020-016-0942-527043843Search in Google Scholar
Bikle DD. Vitamin D, metabolism, mechanism of action, and clinical applications. Chem Biol. 2014; 21(3): 319-329.BikleDDVitaminDmetabolism, mechanism of action, and clinical applicationsChem Biol201421331932910.1016/j.chembiol.2013.12.016396807324529992Search in Google Scholar
Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y. Vitamin D and autoimmunity. Scand J Rheumatol. 2016; 45(6): 439-447.RosenYDaichJSolimanIBrathwaiteEShoenfeldYVitamin D and autoimmunityScand J Rheumatol201645643944710.3109/03009742.2016.115107227191042Search in Google Scholar
Altieri B, Muscogiuri G, Barrea L, Mathieu C, Vallone CV, Mascitelli L, et al. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord. 2017; 18(3): 335-346.AltieriBMuscogiuriGBarreaLMathieuCValloneCVMascitelliLet alDoes vitamin D play a role in autoimmune endocrine disorders? A proof of conceptRev Endocr Metab Disord201718333534610.1007/s11154-016-9405-928070798Search in Google Scholar
Meng S, He ST, Jiang WJ, Xiao L, Li DF, Xu J, et al. Genetic susceptibility to autoimmune thyroid diseases in a Chinese Han population: Role of vitamin D receptor gene polymorphisms. Ann Endocrinol. 2015; 76(6): 684-689.MengSHeSTJiangWJXiaoLLiDFXuJet alGenetic susceptibility to autoimmune thyroid diseases in a Chinese Han population: Role of vitamin D receptor gene polymorphismsAnn Endocrinol201576668468910.1016/j.ando.2015.01.00326593863Search in Google Scholar
Gao XR, Yu YG. Meta-analysis of the association between vitamin D receptor polymorphisms and the risk of autoimmune thyroid disease. Int J Endocrinol. 2018; 2018: 2846943. doi: 10.1155/2018/2846943. eCollection.GaoXRYuYGMeta-analysis of the association between vitamin D receptor polymorphisms and the risk of autoimmune thyroid diseaseInt J Endocrinol201820182846943doi10.1155/2018/2846943eCollection588533429765404Open DOISearch in Google Scholar
Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2): 143-156.UitterlindenAGFangYVan MeursJBPolsHAVan Leeuwen JPGenetics and biology of vitamin D receptor polymorphismsGene2004338214315610.1016/j.gene.2004.05.01415315818Search in Google Scholar
Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001; 19: 275-290.RavetchJVBollandSIgG Fc receptorsAnnu Rev Immunol20011927529010.1146/annurev.immunol.19.1.27511244038Search in Google Scholar
Takai T. Fc Receptors and Their Role in Immune Regulation and Autoimmunity. J Clin Immunol. 2005; 25(1): 1-18.TakaiTFc Receptors and Their Role in Immune Regulation and AutoimmunityJ Clin Immunol200525111810.1007/s10875-005-0353-815742153Search in Google Scholar
Estienne V, Duthoit C, Reichert M, Praetor A, Carayon P, Hunziker W, et al. Androgen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves’ disease: a possible molecular clue for sex dependence of autoimmune disease. FASEB J. 2002; 16(9): 1087-1092.EstienneVDuthoitCReichertMPraetorACarayonPHunzikerWet alAndrogen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves’ disease: a possible molecular clue for sex dependence of autoimmune diseaseFASEB J20021691087109210.1096/fj.01-0998hyp12087070Search in Google Scholar
Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, et al. Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses. Blood. 2009; 113(16): 3716-3725.BruhnsPIannascoliBEnglandPMancardiDAFernandezNJorieuxSet alSpecificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclassesBlood2009113163716372510.1182/blood-2008-09-17975419018092Search in Google Scholar
Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992; 39(5): 225-235.OlerupOZetterquistHHLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantationTissue Antigens199239522523510.1111/j.1399-0039.1992.tb01940.x1357775Search in Google Scholar
Boumazos S, Grinfeld J, Alexander KM, Murchison JT, Wallace WA, McFarlane P, et al. Association of FcyRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression. BMC Pulm Med. 2010; 10:51.BoumazosSGrinfeldJAlexanderKMMurchisonJTWallaceWAMcFarlanePet alAssociation of FcyRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progressionBMC Pulm Med2010105110.1186/1471-2466-10-51295899120929558Search in Google Scholar
Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, et al. Lack of association of the vitamin D receptor gene with Graves’ disease in UK Caucasians. Clin Endocrinol. 2004; 60(5): 618-624.CollinsJEHewardJMNithiyananthanRNejentsevSToddJAFranklynJAet alLack of association of the vitamin D receptor gene with Graves’ disease in UK CaucasiansClin Endocrinol200460561862410.1111/j.1365-2265.2004.02015.x15104566Search in Google Scholar
Zarrin R, Bagheri M, Mehdizadeh A, Ayremlou P, Faghfouri AH. The association of FokI and Apal polymorphisms in vitamin D receptor gene with autoimmune thyroid diseases in the northwest of Iran. Med J Islam Repub Iran. 2018; 32:4. doi: 10.14196/mjiri.32.4. eCollection 2018.ZarrinRBagheriMMehdizadehAAyremlouPFaghfouriAHThe association of FokI and Apal polymorphisms in vitamin D receptor gene with autoimmune thyroid diseases in the northwest of IranMed J Islam Repub Iran2018324doi10.14196/mjiri.32.4eCollection 2018602591529977872Open DOISearch in Google Scholar
Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013; 9(5): 277-287.SimmondsMJGWAS in autoimmune thyroid disease: redefining our understanding of pathogenesisNat Rev Endocrinol20139527728710.1038/nrendo.2013.5623529038Search in Google Scholar
Maciej ewski A, Kowalczyk MJ, Herman W, Czyzyk A, Kowalska M, Żaba R, et al. Vitamin D receptor gene polymorphisms and autoimmune thyroiditis: Are they associated with disease occurrence and its features? Biomed Res Int. 2019; 2019:8197580. doi: 10.1155/2019/8197580. eCollection 2019.Maciej ewskiAKowalczykMJHermanWCzyzykAKowalskaMŻabaRet alVitamin D receptor gene polymorphisms and autoimmune thyroiditis: Are they associated with disease occurrence and its features?Biomed Res Int201920198197580doi10.1155/2019/8197580eCollection 2019Open DOISearch in Google Scholar
Horst-Sikorska W, Ignaszak-Szczepaniak M, Marcinkowska M, Kaczmarek M, Stajgis M, Slomski R. Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves’ disease. Acta Biochim Pol. 2008; 55(2): 371-380.Horst-SikorskaWIgnaszak-SzczepaniakMMarcinkowskaMKaczmarekMStajgisMSlomskiRAssociation analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves’ diseaseActa Biochim Pol200855237138010.18388/abp.2008_3085Search in Google Scholar
Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes. 2000; 49(3): 504-507.PaniMAKnappMDonnerHBraunJBaurMPUsadelKHet alVitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in GermansDiabetes200049350450710.2337/diabetes.49.3.504Search in Google Scholar
Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001; 177(1-2): 145-159.WhitfieldGKRemusLSJurutkaPWZitzerHOzaAKDangHTet alFunctionally relevant polymorphisms in the human nuclear vitamin D receptor geneMol Cell Endocrinol20011771-214515910.1016/S0303-7207(01)00406-3Search in Google Scholar
Boumazos S, Hart SP, Chamberlain LH, Glennie MJ, Dransfield I. Association of FcγRIIa (CD32a) with lipid rafts regulates ligand binding activity. J Immunol. 2009; 182(12): 8026-8036.BoumazosSHartSPChamberlainLHGlennieMJDransfieldIAssociation of FcγRIIa (CD32a) with lipid rafts regulates ligand binding activityJ Immunol2009182128026803610.4049/jimmunol.090010719494328Search in Google Scholar
Mikoś H, Mikoś M, Obara-Moszynsk M, Niedziela M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol. 2014; 65(2): 150-155.MikośHMikośMObara-MoszynskMNiedzielaMThe role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD)Endokrynol Pol201465215015510.5603/EP.2014.002124802739Search in Google Scholar
Stein T, Wollschlegel A, Te H, Weiss J, Joshi K, Kinzel B, et al. Interferon regulatory factor 5 and nuclear factor k-B exhibit cooperating but also divergent roles in the regulation of pro-inflammatory cytokines important for the development of TH1 and TH17 responses. FEBS J. 2018; 285(16): 3097-3113.SteinTWollschlegelATeHWeissJJoshiKKinzelBet alInterferon regulatory factor 5 and nuclear factor k-B exhibit cooperating but also divergent roles in the regulation of pro-inflammatory cytokines important for the development of TH1 and TH17 responsesFEBS J2018285163097311310.1111/febs.1460029971953Search in Google Scholar
Yesmin K, Hargreaves C, Newby PR, Brand OJ, Heward JM, Franklyn JA, et al. Association of FcγRIIa with Graves’ disease: A potential role for dysregulated autoantibody clearance in disease onset/ progression. Clin Endocrinol (Oxf). 2010; 73(1): 119-125.YesminKHargreavesCNewbyPRBrandOJHewardJMFranklynJAet alAssociation of FcγRIIa with Graves’ disease: A potential role for dysregulated autoantibody clearance in disease onset/ progressionClin Endocrinol (Oxf)201073111912510.1111/j.1365-2265.2010.03780.xSearch in Google Scholar
Choi YM, Kwak MK, Hong SM, Hong EG. Changes in thyroid peroxidase and thyroglobulin antibodies might be associated with Graves’ disease relapse after antithyroid drug therapy. Endocrinol Metab (Seoul). 2019; 34(3): 268-274.ChoiYMKwakMKHongSMHongEGChanges in thyroid peroxidase and thyroglobulin antibodies might be associated with Graves’ disease relapse after antithyroid drug therapyEndocrinol Metab (Seoul)201934326827410.3803/EnM.2019.34.3.268676933931565879Search in Google Scholar
